ClearNote Secures $52 Million in Latest Series D Funding Round

ClearNote secured $52 million in its latest Series D, adding another data point to the Healthcare & Life Sciences funding market.

ClearNote Raises $52 million in Funding

ClearNote Secures $52M Series D Fund. Published: Thu, 28 May 2026 07:00:00 GMT ClearNote Health Raises $52M and Adds Kevin Keegan to Scale Early Cancer Detection Platform - citybiz.

Investors Behind the Funding

The round was backed by undisclosed investors. Market Tape tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

ClearNote operates in Healthcare & Life Sciences. ClearNote's Series D round shows investors are still backing digital health platforms with real scale narratives. At $52M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

Accelerate Growth in Early Cancer Detection - Business Wire.

Looking Ahead

ClearNote Secures $52M Series D Fund

Source reference: original announcement/article.